Hostname: page-component-7c8c6479df-27gpq Total loading time: 0 Render date: 2024-03-28T18:28:03.043Z Has data issue: false hasContentIssue false

Cerebrospinal Fluid Vasopressin—Changes in Depression

Published online by Cambridge University Press:  29 January 2018

Annette Gjerris
Affiliation:
University Department of Psychiatry, Rigshospitalet, 9 Blegdamsvej, 2100-DK Copenhagen, Denmark
Per Vendsborg
Affiliation:
Sct. Hans Hospital, Roskilde
Mogens Hammer
Affiliation:
University Department of Medicine, Rigshospitalet, Copenhagen
Niels Juel Christensen
Affiliation:
University Department of Medicine, Herlev Hospital, Copenhagen
Ole J. Rafaelsen
Affiliation:
Rigshospitalet, Copenhagen

Abstract

Cerebrospinal flud (CSF), thyrotropin releasing hormone (TRH), CSF-vasopressin (AVP), plasma-AVP, CSF-osmolality, plasma-osmolality, CSF-adrenaline (A) and -noradrenaline (NA) were measured in psychiatric patients and controls. Psychiatric patients were classified according to ICD-9 and grouped into endogenous depression, non-endogenous depression, mania and schizophrenia. The depressive groups were classified according to the Newcastle Rating Scale for Depression 1965. Severity of disease was quantified by BRMES, BRMS and BPRS. No difference in CSF-TRH levels was seen among the different diagnostic groups and controls. A positive correlation between CSF-TRH and CSF-A was demonstrated. CSF-AVP concentrations were significantly lowered in both endogenous and non-endogenous depression; no correlation with CSF-A or -NA was seen. Neither did any difference between plasma levels of AVP, plasma-osmolality or CSF-osmolality appear among the groups investigated.

Type
Papers
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akiskal, H. S. & Mckinney, W. T. (1973) Depressive disorders: Towards a unified hypothesis. Science, 18, 2029.CrossRefGoogle Scholar
Bech, P., Bolwig, T. G., Kramp, P. & Rafaelsen, O. J. (1979) The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale —Evaluation of homogeneity and inter-observer reliability. Acta Psychiatrica Scandinavica, 59, 420430.CrossRefGoogle Scholar
Bech, P., Gjerris, A., Andersen, J., Bøjholm, S., Kramp, P., Bolwig, T. G., Rastrup, M., Clemmesen, L. & Rafaelsen, O. J. (1983) The Melancholia Scale and the Newcastle Scales: Item combination and interobserver-reliability. British Journal of Psychiatry, 143, 5863.CrossRefGoogle Scholar
Bech, P. & Rafaelsen, O. J. (1980) The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatrica Scandinavica, 62, Suppl. 285, 128132.CrossRefGoogle Scholar
Blake, R. D., Dodd, M. J. & Evans, J. G. (1978) Vasopressin in amnesia. Lancet, i, 608.CrossRefGoogle Scholar
Blessing, W. W. Sved, A. F. & Reis, D. J. (1982) Destruction of noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension. Science, 217, 661662.CrossRefGoogle ScholarPubMed
Carney, M. W. P., Roth, M. & Garside, R. F. (1965) The diagnosis of depressive syndromes and prediction of ECT response. British Journal of Psychiatry, 111, 659674.CrossRefGoogle Scholar
Christensen, N. J., Gjerris, A., Barry, D. & Rafaelsen, O. J. (1984) Assessment of the activity of the brain catecholamine neuron systems in man. Clinical Neuropharmacology, 7, Suppl. 1, 682683.CrossRefGoogle Scholar
Christensen, N. J., Vestergaard, P., Sørensen, T. & Rafaelsen, O. J. (1980) Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatrica Scandinavica, 61, 178182.CrossRefGoogle ScholarPubMed
Coughlan, A. K. & Hollows, S. E. (1984) Use of memory tests in differentiating organic disorder from depression. British Journal of Psychiatry, 145, 164167.CrossRefGoogle ScholarPubMed
Cronholm, B. & Ottosson, J. O. (1961) Memory functions in endogenous depression. Archives of General Psychiatry, 5, 193199.CrossRefGoogle ScholarPubMed
De Wied, D. (1976) Behavioural effects of intraventricularly administered vasopressin and vasopressin fragments. Life Sciences, 19, 685690.CrossRefGoogle ScholarPubMed
Doris, P. A. (1984) Vasopressin and central integrative processes. Neuroendocrinology, 38, 7585.CrossRefGoogle ScholarPubMed
Eysenck, M. W. (1982) Attention and arousal. Berlin: Springer.CrossRefGoogle Scholar
Fehm-Wolfsdorf, G., Born, J., Voigt, K.-H. & Fehm, H. L. (1984) Behavioral effects of vasopressin. A single case study. Neuropsychobiology, 11, 4953.CrossRefGoogle Scholar
Friedman, A. S. (1964) Minimal effects of severe depression on cognitive functioning. Journal of Abnormal and Social Psychology, 69, 237243.CrossRefGoogle ScholarPubMed
Gjerris, A., Bech, P., Andersen, J., Bojholm, S., Kramp, P., Bolwig, T. G., Rastrup, M., Clemmesen, L. & Rafaelsen, O. J. (1984) The Melancholia Scale, the Newcastle Scales, and the Eighth International Classification of Disease: Interobserver reliability and diagnostic validity. In Biological Psychiatry: Recent Studies (ed. Burrows, G. D.). London: John Libbey & Company Limited, pp. 121125.Google Scholar
Gjerris, A., Jensen, E., Christensen, N. J. & Rafaelsen, O. J. (1981) Adrenaline and noradrenaline in psychiatric disorders. In Biological Psychiatry (eds. Perris, C., Struwe, G. & Jansson, B.). Amsterdam: Elsevier/North Holland Biomedical Press, 565568.Google Scholar
Gold, P. W., Goodwin, F. K., Post, R. M., & Robertson, G. L. (1981) Neuroendocrine studies of depressive disorders. Psychopharmacology Bulletin, 17, 79.Google Scholar
Gold, P. W., Goodwin, F. K. & Reus, V. I. (1978) Vasopressin in affective illness. Lancet, i, 12331236.CrossRefGoogle Scholar
Gold, P. W., Weingartner, H., Ballenger, J. C., Goodwin, F. K. & Post, R. M. (1979) Effects of 1-deamino-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder. Lancet, ii, 992994.CrossRefGoogle Scholar
Hammer, M. (1978) Radioimmunoassay of 8-argine-vasopressin (antidiuretic hormone) in human plasma. Scandinavian Journal of Clinical and Laboratory Investigation, 38, 707716.CrossRefGoogle ScholarPubMed
Heshe, J., Röder, E. & Theilgaard, A. (1978) Unilateral and bilateral ECT. Acta Psychiatrica Scandinavica, Suppl. 273, 6487.Google Scholar
Johnstone, E. C. & Ferrier, I. N. (1981) Neuroendocrine markers on CNS drug effects. In Methods in Clinical Pharmacology — Central Nervous System (eds. Lader, M. & Richens, A.). London, Basingstoke: The MacMillan Press Ltd., 319.CrossRefGoogle Scholar
Kastin, A. J., Ehrensing, R. H., Schalch, D. S. & Andersen, M. S. (1972) Improvement in mental depression with decreased thyrotropin-releasing hormone. Lancet, ii, 740742.CrossRefGoogle Scholar
Kirkegaard, C. (1983) Serum thyrotropin responset efter stimulation med thyreotropin-releasing hormon hos patienter med endogen depression. Thesis. Copenhagen: FADL's Forlag.Google Scholar
Kirkegaard, C., Faber, J., Hummer, L. & Ragowski, P. (1979) Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology, 4, 227235.CrossRefGoogle ScholarPubMed
Korsgaard, S. Casey, D. E., Pedersen, N. E. D., Jørgensen, A. & Gerlach, J. (1981) Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo. Psychopharmacology, 74, 379382.CrossRefGoogle ScholarPubMed
Laakmann, G. (1980) Neuroendocrinological findings in affective disorders after administration of antidepressants. Advances in Biological Psychiatry, 5, 6784.CrossRefGoogle Scholar
Leboeuf, A., Lodge, J. & Eames, P. G. (1978) Vasopressin and memory in Korsakoff syndrome. Lancet, ii, 1370.CrossRefGoogle Scholar
Legros, J. J., Gilot, P., Seron, X., Claessens, J., Adam, A., Moeglen, J. M., Audibert, A. & Berchier, P. (1978) Influence of vasopressin on learning and memory. Lancet, i, 4142.CrossRefGoogle Scholar
Lerer, B., Zabow, T., Egnal, N. & Belmaker, R. H. (1983) Effect of vasopressin on memory following electroconvulsive therapy. Biological Psychiatry, 18, 821824.Google ScholarPubMed
Lingjaerde, O. (1983) The biochemistry of depression. A survey of monoaminergic, neuroendocrinological, and bio-rhythmic disturbances in endogenous depression. Acta Psychiatrica Scandinavica, Suppl. 302, 3651.CrossRefGoogle Scholar
Loosen, P. T. & Prange, A. J. (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. The American Journal of Psychiatry, 139, 405416.Google ScholarPubMed
Martin, J. B., Reichlin, S. & Brown, G. M. (1977) Clinical neuroendocrinology. Philadelphia: F. A. Davis Co.Google ScholarPubMed
Oliveros, J. C., Jandali, M. K., Timsit-Berthier, M., Remy, R., Benghezal, A., Audibert, A. & Moeglen, J. M. (1978) Vasopressin in amnesia. Lancet, i, 42.CrossRefGoogle Scholar
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.CrossRefGoogle Scholar
Prange, A. J. Jr., Lara, P. P., Wilson, I. C., Alltop, L. B. & Breese, G. R. (1972) Effects of thyrotropin-releasing hormone in depression. Lancet, ii, 991002.Google Scholar
Pribram, K. H. & Mcguinness, D. (1975) Arousal, activation and effort in the control of attention. Psychological Review, 82, 116149.CrossRefGoogle ScholarPubMed
Reding, M. J. & Diponte, P. (1983) Vasopressin in Alzheimer's disease. Neurology, 33, 16341635.CrossRefGoogle ScholarPubMed
Reichlin, S. (1974) Neuroendocrinology. In Textbook of Endocrinology, 5th ed. (ed. Williams, R. H.). Philadelphia: W. B. Saunders Co.Google Scholar
Reppert, S. M., Artman, H. G., Swaminathan, S. & Fischer, D. A. (1981) Vasopressin exhibits a rhythmic daily pattern in cerebrospinal fluid but not in blood. Science, 213, 12561257.CrossRefGoogle Scholar
Sahgal, A. (1984) A critique of the vasopressin-memory hypothesis. Psychopharmacology, 83, 215228.CrossRefGoogle ScholarPubMed
Schwartz, W. J., Coleman, R. J. & Reppert, S. M. (1983) A daily vasopressin rhythm in rat cerebrospinal fluid. Brain Research, 263, 105112.CrossRefGoogle ScholarPubMed
Siegel, S. (1956) Non-parametric statistics. New York: McGraw Hill.Google Scholar
Sørensen, P. S., Gjerris, A. & Hammer, M. (1985) Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. Journal of Neurology, Neurosurgery and Psychiatry, 48, 5057.CrossRefGoogle ScholarPubMed
Sørensen, P. S., Hammer, M. & Bolwig, T. G. (1982) Vasopressin release during electroconvulsive therapy. Psychoneuroendocrinology, 7, 303308.CrossRefGoogle ScholarPubMed
Strömgren, L. S. (1977) The influence of depression on memory. Acta Psychiatrica Scandinavica, 56, 109128.CrossRefGoogle ScholarPubMed
Tamminga, C. A., Durso, R., Fedio, P. & Chase, T. N. (1982) Vasopressin studies in Alzheimer's disease. Psychopharmacology Bulletin, 18, 4849.Google Scholar
Tanaka, M., de Kloet, E. R., De Wied, D., & Versteeg, D. H. G. (1977) Arginine-8-vasopressin affects catecholamine metabolism in specific brain nuclet. Life Sciences, 20, 17991808.CrossRefGoogle Scholar
Vanderwolf, C. H. & Robinson, T. E. (1981) Reticulo-cortical activity and behaviour: A critique of the arousal theory and a new synthesis. The Behavioural and Brain Sciences, 4, 459514.CrossRefGoogle Scholar
Weingartner, H., Gold, P., Ballenger, J. C., Smallberg, S. A., Summers, R., Rubinow, D. R., Post, R. M., & Goodwin, F. K. (1981) Effects of vasopressin on human memory functions. Science, 211, 601603.CrossRefGoogle ScholarPubMed
Wood, J. H. (1983) Physiology and pharmacology of hormones in CSF. In Neurobiology of Cerebrospinal Fluid 2 (ed. Wood, J. H.). New York: Plenum Press, pp. 4365.CrossRefGoogle Scholar
World Health Organisation (1978). Glossary of mental disorders and guide to their classification for use in conjunction with the International Classification of Disease, 9th revision. Geneva: WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.